Home/Syna Therapeutics/Gabriel Roig
GR

Gabriel Roig

Chairman of the Board

Syna Therapeutics

Therapeutic Areas

Syna Therapeutics Pipeline

DrugIndicationPhase
LB-0702Hematology pathologiesPre-clinical